Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Jaguar Animal Health, Inc. (JAGX)

Biodexa Pharmaceuticals PLC Unsponsored ADR and Jaguar Animal Health, Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $1.3M against $950.0K — 1.3× the size. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against 60.2%. Jaguar Animal Health, Inc. has the higher net margin (−188.5% vs −1,155.7%) and the lower return on invested capital (−28,393.6% vs 0.00%). Across the 17 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 11 and Jaguar Animal Health, Inc. on 6.

Valuation

Metric BDRX JAGX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.00 9.40
P/B n/m 0.00 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.20 0.14 0.66
EV/Sales (2.81) (0.12) 9.02
Earnings yield (102.95%) (1,425,993.60%) (32.88%)
Free cash flow yield 0.00% (34,129.63%) (23.13%)

Profitability

Metric BDRX JAGX Biotechnology median
Gross margin 0.00% 82.31% 68.51%
Operating margin 0.00% (93.10%) 0.00%
Net margin (1,155.70%) (188.46%) 0.00%
Free cash flow margin 0.00% (24.03%) 0.00%
Return on equity 0.00% (1,125.38%) (51.96%)
Return on assets 0.00% (127.14%) (46.06%)
Return on invested capital 0.00% (28,393.64%) 0.00%

Growth

Metric BDRX JAGX Biotechnology median
Revenue growth (TTM) 60.22% 135.52% 6.76%
EPS growth (last fiscal year) 89.62% 82.42% 29.88%
Revenue growth, 5-year CAGR (28.78%) 4.17% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX JAGX Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 2.41 0.69 4.97
Net debt to EBITDA 1.00 (0.17) 1.01

Dividend

Metric BDRX JAGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BDRX JAGX Biotechnology median
Market cap 1.25m 950.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack